… Adjuvant intravesical therapy has revolutionized the … Bladder cancer lends itself to
intravesical therapy because of the ability to provide direct contact of the agent with the bladder …

… and prognostic benefit in non-muscle-invasive bladder cancer … Adjuvant intravesical therapy
with either immunotherapy or … and role of intravesical therapies in reducing recurrence and …

… to boost the efficacy of intravesical therapy for bladder cancer are promising. In this review,
we highlight the advances in intravesical therapy in the management of TCC of the bladder. …

… Intravesical therapy should be seriously considered, as a … data to indicate which intravesical
agent is most appropriate for … BCG may be the most effective intravesical agent in the …

… , it is necessary to consider adjuvant intravesical therapy in most patients. Intravesical therapy
involves instillation of a therapeutic agent directly into the bladder. Commonly used agents …

… the clinical benefit of intravesical therapy and provide clinical … analyses of intravesical therapy
for superficial bladder cancer. … , further intravesical induction and maintenance therapy with …

… and harms of intravesical therapies for nonmuscle invasive bladder cancer. … intravesical
therapy vs no intravesical therapy as well as trials that compared 2 or more intravesical therapies…

… bladder cancer … bladder cancer have a recurrence rate of 50% to 70%, in patients who
survive 15 years, the recurrence rate averages 88%.2, 6, 13, 15, 3D, 37 Often, intravesical therapy …

… bladder cancer. Herein, we review the literature and describe optimal use of intravesical
therapies for … was performed and highlighted in this review of intravesical therapy for NMIBC. …

… of bladder tissues during and after intravesical therapy can be … To our knowledge, intravesical
therapy of bladder cancer … the current status of intravesical therapy, and the application of …